ClinicalTrials.Veeva

Menu

Nasopharyngeal Streptococcus Pneumoniae Carriage

Pfizer logo

Pfizer

Status

Completed

Conditions

Streptococcus Pneumoniae Infections

Study type

Observational

Funder types

Industry

Identifiers

NCT00471822
0887X-101849
B1841034

Details and patient eligibility

About

Primary Objective: Evaluation of the

  • Carriage rate of Streptococcus pneumoniae in the nasopharynx of children

Secondary Objective:

  • Carriage rate and distribution of Streptococcus pneumoniae serotypes
  • Estimation of prevalence rate of antibiotic-resistant Streptococcus pneumoniae strains
  • Distribution of Staphylococcus aureus strain
  • The influence of risk factors in the Streptococcus pneumoniae carriage rate in children

Enrollment

9,707 patients

Sex

All

Ages

2 months to 5 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Children aged between 2 months and 5 years attending pediatric clinics in hospitals, day care centers or kindergartens.
  2. Informed consent obtained from parents or legal guardian.

Exclusion criteria

  1. Children younger than 2 months of age.
  2. Children with following serious diseases: immunological disease, neoplastic disease, renal, cardiac or hematological disease, bronchodysplasia, Down's syndrome.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems